Lingeng Lu MD, PhD

Research Scientist in Epidemiology (Chronic Diseases)

Departments & Organizations

School of Public Health


Research Interests

Cancer etiology; Cancer diagnostic and prognostic markers; Personalized therapy  more...


Education

  • M.D., Shanghai Medical University, 1991
  • Ph.D., Texas A & M University, 2004

Selected Publications

  • Lu L, Risch E, Deng Q, Biglia N, Picardo E, Katsaros D, Yu H. An insulin-like growth factor-II intronic variant affects local DNA conformation and ovarian cancer survival. Carcinogenesis. 2013 Jun 17. [Epub ahead of print]
  • Setiawan VW, Yang HP, Pike MC, McCann SE, Yu H, Xiang YB, Wolk A, Wentzensen N, Weiss NS, Webb PM, van den Brandt PA, van de Vijver K, Thompson PJ; Australian National Endometrial Cancer Study Group, Strom BL, Spurdle AB, Soslow RA, Shu XO, Schairer C, Sacerdote C, Rohan TE, Robien K, Risch HA, Ricceri F, Rebbeck TR, Rastogi R, Prescott J, Polidoro S, Park Y, Olson SH, Moysich KB, Miller AB, McCullough ML, Matsuno RK, Magliocco AM, Lurie G, Lu L, Lissowska J, Liang X, Lacey JV Jr, Kolonel LN, Henderson BE, Hankinson SE, Håkansson N, Goodman MT, Gaudet MM, Garcia-Closas M, Friedenreich CM, Freudenheim JL, Doherty J, De Vivo I, Courneya KS, Cook LS, Chen C, Cerhan JR, Cai H, Brinton LA, Bernstein L, Anderson KE, Anton-Culver H, Schouten LJ, Horn-Ross PL. 2013. Type I and II endometrial cancers: have they different risk factors? J Clin Oncol. 31(20):2607-18. doi: 10.1200/JCO.2012.48.2596
  • Risch HA, Lu L, Wang J, Zhang W, Ni Q, Gao YT, Yu H. 2013. ABO blood group and risk of pancreatic cancer: a study in Shanghai and meta-analysis. Am J Epidemiol. 177(12):1326-37. doi: 10.1093/aje/kws458

more...

collapsible-single-column-one-thumbnailphotobooksupi=12041411/WCF/News.svc/

Latest News

3
more...

Edit Profile